These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33806216)

  • 1. Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test.
    Šimánek V; Pecen L; Krátká Z; Fürst T; Řezáčková H; Topolčan O; Fajfrlík K; Sedláček D; Šín R; Pazdiora P; Zelená H; Slouka D; Kučera R
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors.
    Szabó Z; Szabó T; Bodó K; Kemenesi G; Földes F; Kristóf K; Barabás E; Vásárhelyi B; Prohászka Z; Fodor E; Jakab F; Berki T; Lacza Z
    Pract Lab Med; 2021 May; 25():e00222. PubMed ID: 33898689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
    Walker GJ; Naing Z; Ospina Stella A; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.
    Terpos E; Politou M; Sergentanis TN; Mentis A; Rosati M; Stellas D; Bear J; Hu X; Felber BK; Pappa V; Pagoni M; Grouzi E; Labropoulou S; Charitaki I; Ntanasis-Stathopoulos I; Moschandreou D; Bouhla A; Saridakis S; Korompoki E; Giatra C; Bagratuni T; Pefanis A; Papageorgiou S; Spyridonidis A; Antoniadou A; Kotanidou A; Syrigos K; Stamoulis K; Panayiotakopoulos G; Tsiodras S; Alexopoulos L; Dimopoulos MA; Pavlakis GN
    Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33260775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test.
    Bal A; Pozzetto B; Trabaud MA; Escuret V; Rabilloud M; Langlois-Jacques C; Paul A; Guibert N; D'Aubarède-Frieh C; Massardier-Pilonchery A; Fabien N; Goncalves D; Boibieux A; Morfin-Sherpa F; Pitiot V; Gueyffier F; Lina B; Fassier JB; Trouillet-Assant S;
    Clin Chem; 2021 Apr; 67(5):742-752. PubMed ID: 33399823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
    Grenache DG; Ye C; Bradfute SB
    J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization.
    Souiri A; Lemriss S; El Maliki B; Falahi H; El Fahime E; El Kabbaj S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies.
    Sekirov I; Petric M; Carruthers E; Lawrence D; Pidduck T; Kustra J; Laley J; Lee MK; Chahil N; Mak A; Levett PN; Mendoza E; Wood H; Drebot M; Krajden M; Morshed M
    Access Microbiol; 2021; 3(8):000257. PubMed ID: 34888485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.
    Yang HS; Racine-Brzostek SE; Lee WT; Hunt D; Yee J; Chen Z; Kubiak J; Cantu M; Hatem L; Zhong E; D'Ambrosio D; Chadburn A; Westblade L; Glesby M; Loda M; Cushing MM; Zhao Z
    Clin Chim Acta; 2020 Oct; 509():117-125. PubMed ID: 32505774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
    Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
    J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test.
    Kim Y; Lee JH; Ko GY; Ryu JH; Jang JH; Bae H; Yoo SH; Choi AR; Jung J; Lee J; Oh EJ
    Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary.
    Wouters E; Steenhuis M; Schrezenmeier H; Tiberghien P; Harvala H; Feys HB; van der Schoot E
    Vox Sang; 2021 May; 116(5):493-496. PubMed ID: 33368373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.